153 related articles for article (PubMed ID: 26648023)
1. Gambogic acid induces apoptosis and sensitizes TRAIL-mediated apoptosis through downregulation of cFLIPL in renal carcinoma Caki cells.
Jang JH; Kim JY; Sung EG; Kim EA; Lee TJ
Int J Oncol; 2016 Jan; 48(1):376-84. PubMed ID: 26648023
[TBL] [Abstract][Full Text] [Related]
2. 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression.
Han MA; Woo SM; Min KJ; Kim S; Park JW; Kim DE; Kim SH; Choi YH; Kwon TK
Chem Biol Interact; 2015 Feb; 228():69-78. PubMed ID: 25619640
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP.
Seo BR; Min KJ; Woo SM; Choe M; Choi KS; Lee YK; Yoon G; Kwon TK
Antioxid Redox Signal; 2017 Aug; 27(4):215-233. PubMed ID: 27927016
[TBL] [Abstract][Full Text] [Related]
4. BAI, a novel Cdk inhibitor, enhances farnesyltransferase inhibitor LB42708-mediated apoptosis in renal carcinoma cells through the downregulation of Bcl-2 and c-FLIP (L).
Jang JH; Cho YC; Kim KH; Lee KS; Lee J; Kim DE; Park JS; Jang BC; Kim S; Kwon TK; Park JW
Int J Oncol; 2014 Oct; 45(4):1680-90. PubMed ID: 24993441
[TBL] [Abstract][Full Text] [Related]
5. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1.
Jang JH; Lee TJ; Yang ES; Min do S; Kim YH; Kim SH; Choi YH; Park JW; Choi KS; Kwon TK
Exp Cell Res; 2010 Aug; 316(13):2194-203. PubMed ID: 20451517
[TBL] [Abstract][Full Text] [Related]
6. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins.
Lee SJ; Noh HJ; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
Int J Oncol; 2011 Feb; 38(2):485-92. PubMed ID: 21170508
[TBL] [Abstract][Full Text] [Related]
7. Dioscin sensitizes cells to TRAIL-induced apoptosis through downregulation of c-FLIP and Bcl-2.
Kim YS; Kim EA; Park KG; Lee SJ; Kim MS; Sohn HY; Lee TJ
Oncol Rep; 2012 Nov; 28(5):1910-6. PubMed ID: 22895655
[TBL] [Abstract][Full Text] [Related]
8. Antimycin A sensitizes cells to TRAIL-induced apoptosis through upregulation of DR5 and downregulation of c-FLIP and Bcl-2.
Lee SJ; Kim EA; Song KS; Kim MJ; Lee DH; Kwon TK; Lee TJ
Int J Oncol; 2012 Oct; 41(4):1425-30. PubMed ID: 22842544
[TBL] [Abstract][Full Text] [Related]
9. Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells.
Jung KJ; Min KJ; Bae JH; Kwon TK
Oncotarget; 2015 Jan; 6(3):1556-68. PubMed ID: 25596735
[TBL] [Abstract][Full Text] [Related]
10. The coffee diterpene kahweol sensitizes TRAIL-induced apoptosis in renal carcinoma Caki cells through down-regulation of Bcl-2 and c-FLIP.
Um HJ; Oh JH; Kim YN; Choi YH; Kim SH; Park JW; Kwon TK
Chem Biol Interact; 2010 Jun; 186(1):36-42. PubMed ID: 20403343
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone induces apoptosis through downregulation of c-FLIP and Bcl-2 in renal carcinoma Caki cells.
Park EJ; Chauhan AK; Min KJ; Park DC; Kwon TK
Oncol Rep; 2016 Oct; 36(4):2261-7. PubMed ID: 27573448
[TBL] [Abstract][Full Text] [Related]
12. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.
Han MA; Lee DH; Woo SM; Seo BR; Min KJ; Kim S; Park JW; Kim SH; Choi YH; Kwon TK
Sci Rep; 2016 Jan; 6():18642. PubMed ID: 26725939
[TBL] [Abstract][Full Text] [Related]
13. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins.
Yang L; Wang Q; Li D; Zhou Y; Zheng X; Sun H; Yan J; Zhang L; Lin Y; Wang X
Apoptosis; 2013 May; 18(5):618-26. PubMed ID: 23371323
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L).
Min KJ; Seo BR; Bae YC; Yoo YH; Kwon TK
Cell Death Dis; 2014 Feb; 5(2):e1063. PubMed ID: 24556678
[TBL] [Abstract][Full Text] [Related]
16. Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2.
Yang ES; Woo SM; Choi KS; Kwon TK
Exp Cell Res; 2011 Nov; 317(18):2592-601. PubMed ID: 21854768
[TBL] [Abstract][Full Text] [Related]
17. ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression.
Liang DY; Huang W; Chang Q; Hou YQ
PLoS One; 2018; 13(2):e0191545. PubMed ID: 29444104
[TBL] [Abstract][Full Text] [Related]
18. Eupafolin enhances TRAIL-mediated apoptosis through cathepsin S-induced down-regulation of Mcl-1 expression and AMPK-mediated Bim up-regulation in renal carcinoma Caki cells.
Han MA; Min KJ; Woo SM; Seo BR; Kwon TK
Oncotarget; 2016 Oct; 7(40):65707-65720. PubMed ID: 27582546
[TBL] [Abstract][Full Text] [Related]
19. Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner.
Park EJ; Min KJ; Choi KS; Kwon TK
Exp Cell Res; 2014 Apr; 323(1):144-154. PubMed ID: 24462458
[TBL] [Abstract][Full Text] [Related]
20. Angelicin potentiates TRAIL-induced apoptosis in renal carcinoma Caki cells through activation of caspase 3 and down-regulation of c-FLIP expression.
Min KJ; Um HJ; Seo SU; Woo SM; Kim S; Park JW; Lee HS; Kim SH; Choi YH; Lee TJ; Kwon TK
Drug Dev Res; 2018 Feb; 79(1):3-10. PubMed ID: 29044596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
